Ulotaront

N/A

Report date: 2024/04/03 10:56:03
NME

Base Information

Drug NameUlotaront
Drug Alias NameSEP-856SEP-363856
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTrace amine-associated receptor 1 agonistsSerotonin 1a (5-HT1a) receptor agonists
TargetsTrace amine-associated receptor 1Serotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorAnxiety Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOtsuka Pharmaceutical Development & Commercialization IncOtsuka Pharmaceutical Co Ltd
Inactive CompaniesSunovion Pharmaceuticals IncSumitomo Pharmaceuticals Co LtdKanae Co Ltd +[4] 
Active IndicationsSchizophreniaDepressive Disorder, MajorAnxiety Disorders
Inactive IndicationsNarcolepsyParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A